Amlodipine labels and packages: Difference between revisions

Revision as of 12:56, 6 March 2014

Amlodipine
NORVASC^®, AMLODIPINE^®, AMLODIPINE BESYLATE^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Amlodipine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

PRINCIPAL DISPLAY PANEL - 5 mg Tablets

Norvasc® 5 mg*

Amlodipine Besylate

10 Tablets

400

PRINCIPAL DISPLAY PANEL - 10 mg Tablets

Norvasc® 10 mg*

Amlodipine Besylate

10 Tablets

@@ Line 5: / Line 5: @@
+PRINCIPAL DISPLAY PANEL - 5 mg Tablets
+Norvasc®  5 mg*
+Amlodipine Besylate
+Tablets
+{|
+| [[image:norvasc7.jpg|400|thumb]]
+|}
+PRINCIPAL DISPLAY PANEL - 10 mg Tablets
+Norvasc® 10 mg*
+Amlodipine Besylate
+Tablets
+{|
+| [[image:norvasc8.jpg|400px|thumb]]
+|}
 <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = NORVASC (AMLODIPINE BESYLATE) TABLET [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44e5ad27-e062-461a-bdf4-192d852fbc49#nlm42230-3 | publisher =  | date =  | accessdate = 6 March 2014 }}</ref>